Silence Therapeutics plc (SLN) market cap
Silence Therapeutics plc (SLN) has a market cap of $1.23B. At the end of fiscal 2025 (December 31, 2025) its market cap was $287.17M. That is 9.8% lower than the $318.21M of fiscal 2024. Today's figure is 328.9% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 13:09 UTC, from Yahoo Finance.
Key facts
- Market cap today
- $1.23B
- Market cap, fiscal 2025
- $287.17M
- Change on fiscal 2024
- −9.8%
- Highest on record
- $644.30Mfiscal 2023
- Lowest on record
- $287.17Mfiscal 2025
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.
Silence Therapeutics plc market cap, in more detail
Across the 4 fiscal year-ends on record (2022–2025), the highest was $644.30M in fiscal 2023 and the lowest $287.17M in fiscal 2025.
Market cap at each fiscal year-end
The last point is today's figure; the others are fiscal year-ends.
Silence Therapeutics plc market cap, year by year
| Fiscal year | Market cap | Change | Year ended | Share price at year-end | Diluted shares |
|---|---|---|---|---|---|
| Today | $1.23B | — | $19.80 | — | |
| 2025 | $287.17M | 9.8% down | $6.08 | 47.23M | |
| 2024 | $318.21M | 50.6% down | $6.88 | 46.25M | |
| 2023 | $644.30M | 31.2% up | $17.37 | 37.09M | |
| 2022 | $490.97M | — | $15.25 | 32.19M |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.
How to read it
It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.
Silence Therapeutics plc, figure by figure
- Silence Therapeutics plc revenue
- Silence Therapeutics plc earnings
- Silence Therapeutics plc earnings per share (EPS)
- Silence Therapeutics plc P/E ratio
- Silence Therapeutics plc P/S ratio
- Silence Therapeutics plc P/B ratio
- Silence Therapeutics plc free cash flow
- Silence Therapeutics plc operating margin
- Silence Therapeutics plc dividend
- Silence Therapeutics plc shares outstanding
- Silence Therapeutics plc total debt
- Silence Therapeutics plc cash on hand
- Silence Therapeutics plc total assets
- Silence Therapeutics plc return on equity (ROE)
- Silence Therapeutics plc return on invested capital (ROIC)
Silence Therapeutics plc (SLN) overview: price, valuation and scorecard
Silence Therapeutics plc market cap: questions and answers
What is Silence Therapeutics plc's market cap?
Silence Therapeutics plc (SLN) has a market cap of $1.23B. At the end of fiscal 2025 (December 31, 2025) its market cap was $287.17M. That is 9.8% lower than the $318.21M of fiscal 2024.
What are the highest and lowest market cap figures on record for Silence Therapeutics plc?
Across the 4 fiscal year-ends on record (2022–2025), the highest was $644.30M in fiscal 2023 and the lowest $287.17M in fiscal 2025.
How is Silence Therapeutics plc's market cap calculated?
Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Silence Therapeutics plc it is on record here for 4 fiscal years, 2022 to 2025.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: market cap
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Silence Therapeutics plc (SLN) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/SLN/market-cap
Underlying data: Yahoo Finance.